Cargando…

Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review

Objective: The objective of this study was to appraise the interrelation between overweight/obesity and the safety and efficacy of COVID-19 vaccination by synthesizing the currently available evidence. Methods: A systematic review of published studies on the safety and efficacy of the COVID-19 vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Cangcang, Lin, Nan, Zhu, Jihua, Ye, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223724/
https://www.ncbi.nlm.nih.gov/pubmed/37243100
http://dx.doi.org/10.3390/vaccines11050996
_version_ 1785050009930039296
author Fu, Cangcang
Lin, Nan
Zhu, Jihua
Ye, Qing
author_facet Fu, Cangcang
Lin, Nan
Zhu, Jihua
Ye, Qing
author_sort Fu, Cangcang
collection PubMed
description Objective: The objective of this study was to appraise the interrelation between overweight/obesity and the safety and efficacy of COVID-19 vaccination by synthesizing the currently available evidence. Methods: A systematic review of published studies on the safety and efficacy of the COVID-19 vaccine in people who were overweight or obese was conducted. Databases including Embase, Medline Epub (Ovid), PsychInfo (Ovid), Web of Science, PubMed, CINAHL, and Google Scholar were searched to identify relevant studies. The databases of the Centers for Disease Control (CDC) and World Health Organization (WHO) were also searched for relevant unpublished and gray literature. Results: Fifteen studies were included in the review. All the included studies used observational study designs; there were ten cohort studies and five cross-sectional studies. The sample size of these studies ranged from 21 to 9,171,524. Thirteen studies reported using BNT162b2 (Pfizer-BioNTech, USA), four reported using ChAdOx-nCov19 (AstraZeneca, U.K), two were reported using CoronaVac (Sinovac, China), and two were reported using mRNA1273 (Moderna, USA). The efficacy and safety of COVID-19 vaccines have been extensively studied in individuals with overweight/obesity. Most studies have shown that the humoral response decreases with increasing BMI. The available evidence does not conclusively indicate that these vaccines are generally safe in this population. Conclusion: While the efficacy of the COVID-19 vaccine may be less than ideal in people who are overweight or obese, it does not mean that obese people should not be vaccinated, as the vaccine can still provide some protection. There is a lack of evidence for conclusions to be drawn about the safety of the vaccine in the population. This study calls on health professionals, policymakers, caregivers, and all other stakeholders to focus on monitoring the possible adverse effects of injections in overweight/obese people.
format Online
Article
Text
id pubmed-10223724
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102237242023-05-28 Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review Fu, Cangcang Lin, Nan Zhu, Jihua Ye, Qing Vaccines (Basel) Systematic Review Objective: The objective of this study was to appraise the interrelation between overweight/obesity and the safety and efficacy of COVID-19 vaccination by synthesizing the currently available evidence. Methods: A systematic review of published studies on the safety and efficacy of the COVID-19 vaccine in people who were overweight or obese was conducted. Databases including Embase, Medline Epub (Ovid), PsychInfo (Ovid), Web of Science, PubMed, CINAHL, and Google Scholar were searched to identify relevant studies. The databases of the Centers for Disease Control (CDC) and World Health Organization (WHO) were also searched for relevant unpublished and gray literature. Results: Fifteen studies were included in the review. All the included studies used observational study designs; there were ten cohort studies and five cross-sectional studies. The sample size of these studies ranged from 21 to 9,171,524. Thirteen studies reported using BNT162b2 (Pfizer-BioNTech, USA), four reported using ChAdOx-nCov19 (AstraZeneca, U.K), two were reported using CoronaVac (Sinovac, China), and two were reported using mRNA1273 (Moderna, USA). The efficacy and safety of COVID-19 vaccines have been extensively studied in individuals with overweight/obesity. Most studies have shown that the humoral response decreases with increasing BMI. The available evidence does not conclusively indicate that these vaccines are generally safe in this population. Conclusion: While the efficacy of the COVID-19 vaccine may be less than ideal in people who are overweight or obese, it does not mean that obese people should not be vaccinated, as the vaccine can still provide some protection. There is a lack of evidence for conclusions to be drawn about the safety of the vaccine in the population. This study calls on health professionals, policymakers, caregivers, and all other stakeholders to focus on monitoring the possible adverse effects of injections in overweight/obese people. MDPI 2023-05-17 /pmc/articles/PMC10223724/ /pubmed/37243100 http://dx.doi.org/10.3390/vaccines11050996 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Fu, Cangcang
Lin, Nan
Zhu, Jihua
Ye, Qing
Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title_full Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title_fullStr Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title_full_unstemmed Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title_short Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review
title_sort association between overweight/obesity and the safety and efficacy of covid-19 vaccination: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223724/
https://www.ncbi.nlm.nih.gov/pubmed/37243100
http://dx.doi.org/10.3390/vaccines11050996
work_keys_str_mv AT fucangcang associationbetweenoverweightobesityandthesafetyandefficacyofcovid19vaccinationasystematicreview
AT linnan associationbetweenoverweightobesityandthesafetyandefficacyofcovid19vaccinationasystematicreview
AT zhujihua associationbetweenoverweightobesityandthesafetyandefficacyofcovid19vaccinationasystematicreview
AT yeqing associationbetweenoverweightobesityandthesafetyandefficacyofcovid19vaccinationasystematicreview